Mergers & Acquisitions

The healthcare industry sees a lot of consolidation between both vendors and healthcare providers this channel tracks mergers and acquisitions between large healthcare systems, community hospitals, private practices, vendors and private equity investors. Health systems have been growing in size substantially in the past decade with mergers with smaller healthcare systems and hospitals. This is largely due to the need to be more efficient amid lower reimbursements and rising costs by building an economy of scale in a larger health system. On the vendor side, mergers have become a common way to reduce research and development costs by purchasing intellectual rights for new technologies, or to purchased companies with new technologies that already have regulatory market clearance. 

Job staffing interview waiting resume hiring workforce

Private equity buyouts increase physician turnover by 265%, study finds

A study by researchers at Brown University and Duke University analyzed the employment records of 200 practices acquired by private equity firms and compared them with unacquired practices to develop some observations.

Vintage neon drug sign at the Walgreens pharmacy on Canal Street in downtown New Orleans.

Walgreens $10B private equity buyout financed by 83% debt

A filing with the  U.S. Securities and Exchange Commission reveals details on how Sycamore Partners intends to pay for the struggling pharmacy chain. 

Vintage neon drug sign at the Walgreens pharmacy on Canal Street in downtown New Orleans.

Walgreens confirms $10B sale to PE, as part of $24B transaction

Sycamore Partners will be purchasing the struggling pharmacy chain for $11.45 a share and putting its VillageMD clinics up for sale. 

Private equity firm to buy Walgreens for $10B, report says

The struggling retail pharmacy chain is reportedly being bought out by Sycamore Partners. The deal could be finalized before the end of the week. 

money business cash flow dollar

Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Federal Trade Comission FTC Sign logo

FTC inquiry pauses $615M healthcare staffing merger

The merger between Aya Healthcare and Cross Country Healthcare was finalized in December 2024 and was expected to close in the first half of this year. It's unclear what information the Federal Trade Commission requested from both companies. 

Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities

The acquisition helps Teleflex expand its interventional and vascular portfolios. Biotronik, meanwhile, is shifting its focus toward implantable devices and digital healthcare. 

FDA approves first therapy for very rare lipid storage disorder

Ctexli (chenodiol) can now be prescribed to patients with cerebrotendinous xanthomatosis, a condition caused by a genetic mutation that leads to cholesterol buildup around vital organs. 

Around the web

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology? 

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.